Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 116 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects

Singhal Neha, Praveen V P, Bhavani Nisha, Menon Arun S, Menon Usha, Abraham Nithya, Kumar Harish, JayKumar R V, Nair Vasantha, Sundaram Shanmugha, Sundaram Padma

Year : 2016| Volume: 20| Issue : 2 | Page no: 157-161

   This article has been cited by
 
1 99mTc-pertechnetate thyroid scintigraphy predicts clinical outcomes in personalized radioiodine treatment for Graves’ disease
Zhao Lina,Zhang Wenqi,Xin Yubo,Wen Qiang,Bail Lin,Guan Feng,Ji Bin
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Graves’ Disease in Senegal: Clinical and Evolutionary Aspects
A. Sarr,D. Diédhiou,N. M. Ndour-Mbaye,D. Sow,I. M. Diallo,S. El Alaoui,M. Diouf,S. N. Diop
Open Journal of Internal Medicine. 2016; 06(03): 77
[Pubmed]  [Google Scholar] [DOI]

 

Read this article